SMH) 53 infectious virus particles and instead results in release of low density Core protein complexes 54 that lack HCV RNA into the cellular supernatant. Overall, our results reveal that NS4A is 55 important for late stages of the HCV lifecycle and suggest that the interaction between NS4A 56 and E1 may regulate the incorporation of viral RNA into the virion for the formation of infectious 57 HCV particles. 62 2003-2013, HCV-related deaths numbered more than any other CDC-reported infectious 63 disease [2]. Despite the availability of newly designed, highly effective direct-acting antivirals, 64 disease prevalence remains high, and no vaccine exists for the virus [3-5]. 65 HCV encodes a single stranded, positive-sense RNA genome of approximately 9.6 66 kilobases in length. Upon virus entry into hepatocytes, the viral genome is translated to form a 67 single polyprotein. The polyprotein is co-and post-translationally cleaved by both host and viral 68 proteases, including the NS3-NS4A viral protein complex, to form ten individual proteins. These 69 ten proteins include both structural proteins, which eventually make up the virion, and non-70 structural proteins, which coordinate RNA replication and the other steps in the viral lifecycle, 71 including virion assembly and envelopment (reviewed in [6]). 72 The late stages of the viral lifecycle, including assembly and envelopment, are just 73 beginning to be dissected. While many details of these processes are not understood, recent 74 work has uncovered several key steps that lead to production of infectious virus. Following RNA 75 replication, HCV RNA is shuttled to the cytosolic lipid droplet where Core protein accumulates, 76 oligomerizes, and recruits the NS3 and NS5A proteins [7-10]. NS5A is thought to play a role in 77 RNA recruitment to the lipid droplet, whereas NS3 binds to Core and likely aids in movement of 78 Core bound to RNA from the lipid droplet to nearby sites on the endoplasmic reticulum (ER) [11-79 16]
Abstract 22 Hepatitis C virus (HCV) assembly and envelopment are coordinated by a complex 23 protein interaction network that includes most of the viral structural and nonstructural proteins.
24
While the nonstructural protein 4A (NS4A) is known to be important for viral particle production, 25 the specific function of NS4A in this process is not well understood. We performed mutagenesis 26 of the C-terminal acidic domain of NS4A and found that mutation of several of these amino 27 acids prevented the formation of the viral envelope, and therefore the production of infectious 28 virions, without affecting viral RNA replication. In an overexpression system, we found that 29 NS4A interacted with several viral proteins known to coordinate envelopment, including the viral 30 E1 glycoprotein. One of the NS4A C-terminal mutations, Y45F, disrupted the interaction of 31 NS4A with E1. Specifically, NS4A interacted with the first hydrophobic region of E1, a region 32 previously described as regulating viral particle production. Supernatants from HCV NS4A Y45F 33 transfected cells had significantly reduced levels of HCV RNA, however they contained 34 equivalent levels of Core protein. Interestingly, the Core protein secreted from these cells 35 formed high order oligomers with a density matching the infectious virus secreted from WT cells.
36
These results suggest that this Y45F mutation in NS4A causes secretion of low density Core 37 particles devoid of genomic HCV RNA. These results corroborate previous findings showing that 38 mutation of the first hydrophobic region of E1 also causes secretion of Core complexes lacking 39 RNA, and therefore suggest that the interaction between NS4A and E1 is involved in the 40 incorporation of viral RNA into infectious HCV particles. Our findings define a new role for NS4A 41 in the HCV lifecycle and help elucidate the protein interactions necessary for production of 42 infectious virus.
Author Summary 44 RNA viruses, which encompass both established and emerging pathogens, pose 45 significant public health challenges. Viruses in the family Flavivirdae, including Dengue virus,
46
Zika virus and hepatitis C virus (HCV), continue to cause morbidity and mortality worldwide. One HCV protein, NS4A, has known functions in several steps of the viral lifecycle, however, 48 how it contributes to viral particle production is not understood. Here, we investigated the role of 49 one region of NS4A, the C-terminal acidic domain, in regulating the viral lifecycle. We found that 50 some of the amino acids within this domain are important for viral envelopment to make 51 infectious particles, specifically through interaction with the E1 glycoprotein. NS4A interacts with 52 the first hydrophobic domain of E1. Disruption of this interaction prevents the production of 
Results

125
A Y45F mutation in the hepatitis C virus NS4A protein causes a decrease in 126 infectious viral titer. 127 The acidic domain of NS4A has significant sequence homology between all HCV 128 genotypes, with amino acids 40-54 in the acidic domain differing by at most 3 amino acids ( Fig   129  1A ). In particular, the tyrosine residue at position 45 is conserved in all seven genotypes of 130 HCV. While previous studies have implicated the acidic domain of NS4A in regulating HCV RNA 131 replication and particle production, the mechanism of this regulation was not explored [40] . We 132 sought to investigate how the NS4A acidic domain contributes to HCV particle production. We 133 engineered a structurally conservative amino acid substitution, changing the tyrosine residue (Y,
134
TAT) at position 45 to a phenylalanine (F, TTT) in the genotype 2a strain of HCV, Japanese 135 fulminant hepatitis-1 (JFH1) [42] . We then generated WT or NS4A Y45F in vitro transcribed 136 RNA and transfected it into Huh7.5 cells. At 3 days post-transfection, while the WT RNA 137 produced more than 3 logs of infectious virus, no titer was detected from cells transfected with 138 the RNA containing the Y45F mutation, as measured by focus forming assay ( Fig 1B) . After 139 several passages, Y45F RNA began to produce infectious virus, and after 14 days it produced 140 equivalent titers to that of the WT virus ( Fig 1B) . Sequencing of the NS4A region of HCV RNA 141 extracted from cells at 1, 3, and 14 days post-transfection revealed that the Y45F mutation had 142 reverted back to WT by day 14, with some reversion detected as early as day 3 ( Fig 1C) . These 143 results reveal that substitution of the tyrosine at position 45 with phenylalanine in NS4A 144 prevents production of infectious HCV, indicating that Tyr-45 is required for the production of 145 infectious virus.
146
The NS4A Y45F mutation in HCV does not alter viral RNA replication. To determine if the loss of infectious HCV production by the NS4A Y45F amino acid 148 change was due to altered HCV RNA replication, we engineered the Y45F mutation into an 149 HCV subgenomic replicon construct containing a luciferase reporter and measured luciferase 150 production over time following transfection of Huh7.5 cells with in vitro transcribed HCV RNA.
151
We found that the HCV replicon RNA with the Y45F mutation in NS4A replicated as efficiently 152 as WT, while the HCV RNA with a lethal mutation in the NS5B RNA dependent RNA 153 polymerase (GND) did not replicate (Fig 2A) . Additionally, the HCV proteins NS3, NS4A and 154 NS5A were expressed in lysates harvested at 48 hours post-transfection of either WT or Y45F 155 RNA, indicating that the Y45F mutation did not affect the production of these viral proteins (Fig   156  2B ). Of note, the epitope of the NS4A antibody is in the C-terminal domain of NS4A that 157 contains Tyr-45. Therefore, the lack of a detectable NS4A band by immunoblotting in the mutant 158 condition suggests that the Y45F mutation prevents NS4A recognition by this antibody (Fig 2B) .
159
Indeed, the fact that HCV RNA replication is not altered by the Y45F mutation indicates that the 160 NS4A protein must be stably expressed, as NS4A is required for HCV RNA replication [36, 40, 161 43]. Since the interaction of NS3 with NS4A is essential for viral replication, we tested if the 162 Y45F mutation impacted this interaction using a co-immunoprecipitation experiment with 163 overexpressed proteins. The results show that the Y45F mutation does not alter NS3-NS4A 164 complex formation ( Fig 2C) . Together, these results indicate that the Y45F mutation in NS4A 165 does not alter HCV RNA replication, HCV protein expression, or NS3-NS4A complex formation.
166 Therefore, the NS4A Y45F mutation in HCV must cause a defect at a later stage of the viral 167 lifecycle.
168
The NS4A Y45F mutation inhibits viral envelopment. 169 As the NS4A Y45F mutation did not alter HCV RNA replication but did prevent infectious 170 virus production, we next tested if this mutation affected viral assembly and envelopment or viral 171 release. We first examined if the Y45F mutation caused a viral release defect by measuring both intracellular and extracellular titer. We transfected Huh7.5 cells with WT, Y45F, or GND 173 HCV RNA, and measured the viral titer from the supernatant (extracellular titer) or from lysates 174 generated by freeze-thaw cycles (intracellular titer) by using a focus forming assay. As before,
175
HCV NS4A Y45F RNA did not produce extracellular titer ( Fig 3A) , and here we found that it also 176 did not produce intracellular titer ( Fig 3B) . Taken together, these results indicate that the Y45F 177 mutation impairs viral particle production prior to the formation of fully infectious virions. Core. We found that while Core was protected from proteinase K digestion in WT, it was not 189 protected in lysates containing the Y45F mutation, similar to ΔE1/E2 ( Fig 3C) . These data 190 indicate that the Y45F mutation prevents envelopment of the virion, resulting in a lack of both 191 intracellular and extracellular viral titer, suggesting that Tyr-45 may be an important residue for 192 HCV envelopment.
193
The acidic domain of NS4A is required for HCV envelopment. 194 Based on our findings that HCV RNA with the NS4A Y45F mutation has a defect in viral 195 envelopment, we hypothesized that other amino acids in the NS4A C-terminal acidic domain 196 may also be required. To test this, we introduced several mutations into the acidic domain of 197 NS4A that were previously found to be important for production of infectious HCV particles 198 (K41A, L44A, and E52A) and tested their effects on viral envelopment [40] . We performed a 199 proteinase K protection assay, as in Figure 3 , and found that the K41A, L44A and E52A mutants 200 all resulted in a quantifiable decrease in protease-resistant Core as compared to WT, 201 suggesting that these mutations also caused a defect in envelope formation ( Figs 4A and 4B ).
202
We additionally tested the impact of these amino acids on RNA replication, HCV protein 203 expression, and production of both intracellular and extracellular titer; and also tested two . We then immunoprecipitated E1 using the HA epitope and found 222 that, indeed, NS4A and E1 can interact during HCV infection ( Fig 5C) . We also tested the 223 interactions of NS4A with p7, NS2, and NS5A, non-structural proteins that all have roles in HCV 224 envelopment [10-12, 17-21, 23, 24]. NS4A did interact with NS5A and this interaction was not 225 altered by the Y45F mutation in NS4A (Fig. S1D ). We found no interaction between 226 overexpressed NS4A WT or Y45F with either NS2 or p7 ( Fig S1C) . Together, these data show 227 that NS4A can bind to Core, E1, E2, and NS5A, and that mutation of NS4A at Tyr-45 disrupts its 228 binding to the E1 protein. ). We therefore created a series of E1 truncation mutants based on these 236 known domains of E1, containing N-terminal Flag tags ( Fig 6A) . We overexpressed the 237 truncation mutants and NS4A-HA in Huh7.5 cells and then performed Flag 238 immunoprecipitations followed by immunoblotting for NS4A-HA. We found that NS4A co-239 immunoprecipitated with E1 aa1-106, aa1-138, and aa67-192, all of which contain the first 240 hydrophobic region of E1, but did not interact with aa1-66 or aa107-192, which lack this region 241 ( Fig 6B) . These data suggest that NS4A binds to E1 via the first hydrophobic region of the 242 protein.
229
NS4A binds to the first hydrophobic region of E1
243
NS4A Y45F results in release of Core oligomers devoid of HCV RNA 244 The first hydrophobic region of E1 has previously been implicated in viral particle 245 production, and several amino acids within this region are important for viral infectivity [47, 48] .
246
Additionally, one specific E1 mutation, D263A (E1 aa71), attenuated viral infectivity and resulted 247 in secreted Core protein but not HCV RNA [48] . Taken together with our findings that NS4A 248 binds to the E1 the hydrophobic region, which contains aaD263, we hypothesized that Y45F 249 may have a similar phenotype as the E1 D263A mutant. Therefore, we measured the secretion 250 of HCV RNA and Core protein into supernatants from cells replicating HCV NS4A WT or Y45F
251
RNA. We found that while the Y45F mutation resulted in lower levels of extracellular HCV RNA, 252 as measured by RT-qPCR, secretion of Core into the supernatant was unaltered as compared 253 to WT (Figs 7A-B) . These results were surprising as we did not expect to detect Core protein in 254 the supernatant secreted from HCV NS4A Y45F transfected cells. Because of these unexpected 255 data, we sought to profile the viral components in supernatants from Y45F cells. We collected 256 and concentrated cellular supernatants from HCV NS4A WT or Y45F transfected cells and then 257 ultracentrifuged these samples over iodixanol gradients. We collected 10 equal fractions from 258 the top, with fraction 1 having the lowest density and fraction 10 having the highest density.
259
Each fraction was analyzed by RT-qPCR for HCV RNA, by focus forming assay for viral titer, 260 and by immunoblot for Core protein. In the WT samples, fractions 2 and 3 had the highest levels 261 of both HCV RNA and viral infectivity ( Fig 7C) . These fractions also contained high molecular 262 weight complexes of Core protein (Fig 7D, lanes 2 and 3) . We observed a second peak of HCV 263 RNA in fractions 7, 8, and 9, along with a small amount of higher density Core protein, however 264 these fractions had significantly less viral infectivity ( Fig 7D, lanes 7-9) . Therefore, the HCV 265 RNA in these higher density fractions is likely non-infectious and may represent secreted 266 membrane-associated RNA from replication complexes [49] . However, we saw little to no 267 infectious viral titer from any fraction in the Y45F samples and found the majority of HCV RNA 268 present in fractions 7-9, while the expected infectious fractions (2-4) had little RNA ( Fig 7C) .
269
Interestingly, high molecular weight complexes of Core protein were still observed in fractions 2-270 4, similar to the distribution of Core in WT samples ( Fig 7D) . The fact that Core forms oligomers 271 and that these were in a different fraction than the peak of HCV RNA suggests that the Y45F mutation results in release of partially formed virions containing Core protein oligomers but 273 devoid of HCV RNA.
Discussion
275
Our results define a new role for NS4A in the late stages of the HCV lifecycle.
276
Specifically, we have found that the acidic domain of NS4A is important for regulating assembly 277 and that mutation of specific amino acids within this domain prevents formation of the viral 278 envelope. Further, we have identified new interactions between NS4A and both structural and 279 non-structural viral proteins. This suggests that NS4A may act as a bridge, linking virion 280 assembly at the lipid droplet and envelopment at the ER, similar to the actions of the NS2 281 protein. Importantly, we found that NS4A binds to E1 and that antagonizing this interaction with 282 one amino acid change in NS4A prevents viral envelopment. We mapped the binding site of 283 NS4A on E1 and found that it interacts with the first hydrophobic region, a region that is known 284 to be important for viral particle production [47, 48] . Finally, we found that the Y45F mutation in 285 NS4A, which prevents envelopment, also results in secretion of noninfectious, incompletely 286 formed virions that are composed of low density Core protein oligomers that lack HCV RNA.
287
Together our results reveal a new role for NS4A in coordinating the proper assembly and 288 envelopment of HCV particles to make infectious virus.
289
The NS4A protein contains only 54 amino acids and yet has three distinct domains with 290 specific functions in the HCV lifecycle. While the functions of the NS4A transmembrane domain 291 and the NS3-interaction domain are largely defined [33], much less is known about the function 292 of the C-terminal region, which contains a high number of acidic amino acids from aa40 to aa54 293 ( Fig 1A) . We found that mutation of several amino acids in the acidic domain, including Y45F, 294 disrupted the formation of the viral envelope and therefore prevented production of infectious 295 virus, without affecting viral RNA replication (Figs 2A, 3A, 3C, and 4) . Indeed, the presence of a 296
Tyr at aa45 of NS4A was so essential for the viral lifecycle that a viral RNA containing the Y45F 297 mutation reverted back to the WT sequence after only a few days of passage in cell culture ( Fig   298  1B-C) . Given that changing a Tyr to Phe is a structurally conservative mutation, removing only the hydroxyl group, it is formally possible that NS4A could be phosphorylated at this tyrosine.
300
However, it is unlikely that lack of phosphorylation of this tyrosine would be the sole contributor 301 to the envelopment defects, as several other amino acids within the region displayed the same 302 phenotypes when mutated (Fig 4) and a Y45A mutation prevented HCV RNA replication 303 altogether ( Fig 4C) [40] . Therefore, the acidic domain likely regulates envelopment through the 304 concerted actions of the amino acids in this acidic region of NS4A.
305
Changing the amino acids in NS4A at K41, L44, Y45, and E52 to alanine all resulted in 306 loss of viral titer due to defects in envelopment (Fig 4) . The acidic domain of NS4A, which has 307 been proposed to have an alpha helical structure, is important for replication, and indeed the In support of this hypothesis, previous work has shown that an adaptive mutation 315 in NS3 partially rescues an assembly defect resulting from the K41A mutation, suggesting that 316 NS4A can cooperate with NS3 via K41 for viral particle production [40] . We found that NS4A
317
WT and Y45F bound NS3 equivalently ( Fig 2C) but that the Y45F mutation prevented NS4A 318 interaction with E1 ( Fig 5A) . This suggests that while both the K41A and Y45F RNAs are 319 defective in HCV envelopment, they may function in NS4A to facilitate different protein-protein 320 interactions that regulate envelopment.
321
Supporting the hypothesis that NS4A interacts with several HCV proteins to coordinate 322 virion envelopment, we did identify several previously unknown interactions of NS4A with both 323 structural and non-structural proteins including Core, E1, E2, and NS5A. Others have shown that compensatory mutations within NS4A rescue assembly and envelopment defects caused 325 by mutations in NS2, however we found that NS4A did not interact with NS2 during 326 overexpression. Therefore, these data suggest that during infection, NS2 and NS4A likely work 327 together through a multi-protein complex or to perform similar roles in the lifecycle [19] . Indeed,
328
NS2 is considered to be the main organizer of envelopment, binding both structural and 329 nonstructural proteins to link viral assembly steps at the lipid droplet to envelopment steps at the 330 ER [17-21, 23, 24]. NS4A also binds to proteins involved in both early (Core, NS3, and NS5A) 331 and later (E1 and E2) steps of assembly and envelopment which could suggest that NS4A may 332 also serve as a link between virion production steps at the lipid droplet and the ER, similar to 333 NS2. Overall, these results suggest that NS2 and NS4A could play similar roles in organizing 334 and facilitating viral envelopment.
335
We found that NS4A binds to E1 and that this interaction is disrupted by the Y45F 336 mutation (Fig 5) , suggesting that the NS4A-E1 interaction is important for envelopment of the 337 virion. The E1 protein has an N-terminal ectodomain, two internal hydrophobic domains, a 338 transmembrane domain and a very short, 2 amino acid cytoplasmic, C-terminal tail ( Fig 6A) [46].
339 Surprisingly, we found that NS4A binds to the first hydrophobic region of the protein (Fig 6B) .
340
This region has also previously been shown to bind to Core, and mutations within this domain 
487
Concentrated supernatants were purified over a 10-50% iodixanol gradient, as previously 488 described [48] . Briefly, at 48 hours post electroporation of HCV RNA in Huh7.5 cells, 489 supernatant was collected, mixed with polyethylene glycol (PEG) 8000 to a final concentration 490 of 8% and incubated with rocking at 4ºC overnight. PEG supernatants were centrifuged at 491 11,000 X g for 30 minutes, supernatant was removed, and remaining pellets were suspended in 492 cold 1X PBS. These resuspensions were layered over a 10-50% iodixanol gradient and 493 centrifuged at 222,000 X g in a SW41 rotor in a Beckman Coulter ultracentrifuge. 10 equal 494 fractions (1ml) were collected with a BioComp piston gradient fractionator, and then viral titer 495 (FFU/ml), HCV RNA copy number, and HCV Core protein (immunoblotting) was measured from 496 each fraction.
497
Statistical Analysis.
498
Student's unpaired t-tests and one-way analysis of variance (ANOVA) were used for statistical 499 analysis of data. Values are presented as mean ± standard error of the mean (n=3 or as 500 indicated). * -P < 0.05, ** -P < 0.01, *** -P < 0.001, **** -P < 0.0001.
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